140 related articles for article (PubMed ID: 25383462)
1. Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke.
Wang CW; Wang JL; Zhang Y; Li Q; Guo SX; Ji SB
Neuroreport; 2014 Dec; 25(18):1447-52. PubMed ID: 25383462
[TBL] [Abstract][Full Text] [Related]
2. Plasma copeptin and long-term outcomes in acute ischemic stroke.
Zhang JL; Yin CH; Zhang Y; Zhao LB; Fu HJ; Feng JC
Acta Neurol Scand; 2013 Dec; 128(6):372-80. PubMed ID: 23614762
[TBL] [Abstract][Full Text] [Related]
3. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
[TBL] [Abstract][Full Text] [Related]
4. Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study.
Dong X; Tao DB; Wang YX; Cao H; Xu YS; Wang QY
Neurol Sci; 2013 Sep; 34(9):1591-5. PubMed ID: 23354601
[TBL] [Abstract][Full Text] [Related]
5. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
[TBL] [Abstract][Full Text] [Related]
6. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
De Marchis GM; Katan M; Weck A; Fluri F; Foerch C; Findling O; Schuetz P; Buhl D; El-Koussy M; Gensicke H; Seiler M; Morgenthaler N; Mattle HP; Mueller B; Christ-Crain M; Arnold M
Neurology; 2013 Apr; 80(14):1278-86. PubMed ID: 23468541
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of copeptin: one-year outcome in patients with acute stroke.
Urwyler SA; Schuetz P; Fluri F; Morgenthaler NG; Zweifel C; Bergmann A; Bingisser R; Kappos L; Steck A; Engelter S; Müller B; Christ-Crain M; Katan M
Stroke; 2010 Jul; 41(7):1564-7. PubMed ID: 20508186
[TBL] [Abstract][Full Text] [Related]
8. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes.
Wang CB; Zong M; Lu SQ; Tian Z
J Diabetes Complications; 2016; 30(8):1532-1536. PubMed ID: 27554438
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.
Wang C; Gao L; Zhang ZG; Li YQ; Yang YL; Chang T; Zheng LL; Zhang XY; Man MH; Li LH
Mol Neurobiol; 2016 Apr; 53(3):1509-1517. PubMed ID: 25650122
[TBL] [Abstract][Full Text] [Related]
10. Serum Copeptin Predicts Severity and Recurrent Stroke in Ischemic Stroke Patients.
Tang WZ; Wang XB; Li HT; Dong M; Ji X
Neurotox Res; 2017 Oct; 32(3):420-425. PubMed ID: 28555260
[TBL] [Abstract][Full Text] [Related]
11. The 90-day prognostic value of copeptin in acute intracerebral hemorrhage.
Wei ZJ; Ou YQ; Li X; Li H
Neurol Sci; 2014 Nov; 35(11):1673-9. PubMed ID: 24798127
[TBL] [Abstract][Full Text] [Related]
12. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
De Marchis GM; Weck A; Audebert H; Benik S; Foerch C; Buhl D; Schuetz P; Jung S; Seiler M; Morgenthaler NG; Mattle HP; Mueller B; Christ-Crain M; Arnold M; Katan M
Stroke; 2014 Oct; 45(10):2918-23. PubMed ID: 25169950
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
[TBL] [Abstract][Full Text] [Related]
14. Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis.
Xu Q; Tian Y; Peng H; Li H
Hypertens Res; 2017 May; 40(5):465-471. PubMed ID: 27904159
[TBL] [Abstract][Full Text] [Related]
15. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
16. Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage.
Zhu XD; Chen JS; Zhou F; Liu QC; Chen G; Zhang JM
Crit Care; 2011; 15(6):R288. PubMed ID: 22126444
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of copeptin in patients with aneurysmal subarachnoid hemorrhage.
Zuo Z; Ji X
J Neuroimmunol; 2019 May; 330():116-122. PubMed ID: 30875611
[TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.
Cheng X; Lian YJ; Ma YQ; Xie NC; Wu CJ
Mol Neurobiol; 2017 Mar; 54(2):895-903. PubMed ID: 26780459
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke.
Li YM; Liu XY
J Neurol Sci; 2015 May; 352(1-2):68-73. PubMed ID: 25868898
[TBL] [Abstract][Full Text] [Related]
20. Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls.
Sarfo FS; Owusu D; Adamu S; Awuah D; Appiah L; Amamoo M; Loglo A; Owolabi M; Ovbiagele B
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):633-644. PubMed ID: 29074065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
